Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Oral and Intranasal Zolmitriptan in Healthy Volunteers
NCT06074016Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Jul 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of zolmitriptan in migraine (2 arms), sponsored by Parc de Salut Mar. Primary endpoints: Heart Rate at 24 hours, Systolic Blood Pressure at 24 hours and 4 more. Started Jul 2023; status: completed.
02
Drugs
zolmitriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06074016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06074016.